Medtech / devices
PrimeC showed a more than 14-month survival benefit in an ALS trial, according to updated long-term data from NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd announced updated long-term survival data from its completed Phase 2b PARADIGM clinical trial of its investigational therapy PrimeC in patients with amyotrophic lateral sclerosis (ALS), according to the company. The analysis [...]
An AI model using gait data before and after hip replacement could help predict which patients will walk close to normal and who may need extra rehabilitation. The tool analyses gait biomechanics, the study of how people walk, using data collected before and after operations in people with hip osteoarthritis, caused by cartilage wear in [...]
Labcorp has launched what it describes as the first FDA-cleared blood test for Alzheimer's disease assessment in primary care settings nationwide. The Elecsys pTau-181 helps clinicians rule out the neurodegenerative disorder by identifying which symptomatic patients aged 55 and older are unlikely to have amyloid pathology, abnormal protein build-up in the brain associated with the [...]
Starlab Space has announced a partnership with Auxilium Biotechnologies to advance 3D bioprinting in orbit. Auxilium will provide orbital 3D bioprinting and biofabrication capabilities (manufacturing biological materials) aboard the Starlab space station to support research and development in regenerative medicine, implantable medical devices and tissue engineering. Regenerative medicine uses the body’s own materials to repair [...]
Dubai Healthcare City has expanded its longevity and pharmaceutical services at the World Health Expo Dubai 2026. The expansion brings together what the free zone describes as a new longevity-led preventive care programme and an AI-driven tele-compounding pharmacy platform. The additions expand the range of personalised care pathways available within the ecosystem, with a focus [...]
An EEG test can identify dementia risk five to seven years before progression to mild cognitive impairment or Alzheimer’s dementia, new research suggests. Using EEG data, which measures the brain’s electrical activity, from older adults with only subjective memory concerns, the longitudinal study found this non-invasive test can flag functional changes long before standard tools [...]
Novo Nordisk will launch an Ozempic pill for diabetes in select doses in the second quarter of this year. The Danish drugmaker said the US Food and Drug Administration has approved Ozempic tablets in 1.5 milligram, 4 milligram and 9 milligram doses. The new Ozempic branding is intended to help patients and healthcare professionals more [...]
Limiting the PTP1B enzyme could slow memory loss in Alzheimer's, pointing to a potential treatment route, new research suggests. The enzyme appears to contribute to memory decline in mice by altering how the brain's immune cells behave, researchers say. Dialling down PTP1B let microglia clear the protein clumps linked to Alzheimer's, known as amyloid-beta plaques. [...]
We round up the latest news in agetech research and innovation, from a human trial in ‘reverse ageing’ to the launch of a domestic longevity pod. Approval has been secured in the United States for the first human trial targeting ‘reverse ageing’. Boston-based company Life Biosciences will shortly commence trials of its ER-100 treatment which [...]
A new AI tool flags early Alzheimer's, identifying about four in five people who would otherwise be missed by clinicians. Trained on UCLA Health patient records and tuned to work more fairly across Black, Latino and Asian patients who are often underdiagnosed, the system aims to find people earlier, when treatment and lifestyle changes can [...]
